180 related articles for article (PubMed ID: 18432029)
1. Tailor-made therapy in rheumatoid arthritis: fact or fiction?
Haroon N; Misra R; Aggarwal A
Isr Med Assoc J; 2008 Feb; 10(2):139-41. PubMed ID: 18432029
[TBL] [Abstract][Full Text] [Related]
2. Early rheumatoid arthritis.
Mitchell KL; Pisetsky DS
Curr Opin Rheumatol; 2007 May; 19(3):278-83. PubMed ID: 17414956
[TBL] [Abstract][Full Text] [Related]
3. The role of current strategies in the future treatment of rheumatoid arthritis.
Weinblatt ME
Rheumatology (Oxford); 1999 Nov; 38 Suppl 2():19-23. PubMed ID: 10646485
[TBL] [Abstract][Full Text] [Related]
4. Strategies to control disease in rheumatoid arthritis with tumor necrosis factor antagonists-an opportunity to improve outcomes.
Keystone EC
Nat Clin Pract Rheumatol; 2006 Nov; 2(11):594-601. PubMed ID: 17075598
[TBL] [Abstract][Full Text] [Related]
5. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.
Saunders SA; Capell HA; Stirling A; Vallance R; Kincaid W; McMahon AD; Porter DR
Arthritis Rheum; 2008 May; 58(5):1310-7. PubMed ID: 18438851
[TBL] [Abstract][Full Text] [Related]
6. Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies.
de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Verpoort KN; Schreuder GM; Ewals JA; Terwiel JP; Ronday HK; Kerstens PJ; Toes RE; de Vries RR; Breedveld FC; Dijkmans BA; Huizinga TW; Allaart CF
Arthritis Rheum; 2008 May; 58(5):1293-8. PubMed ID: 18438829
[TBL] [Abstract][Full Text] [Related]
7. Established rheumatoid arthritis: clinical assessments.
van Riel PL; Fransen J
Best Pract Res Clin Rheumatol; 2007 Oct; 21(5):807-25. PubMed ID: 17870029
[TBL] [Abstract][Full Text] [Related]
8. The pharmacogenetics of methotrexate.
Hider SL; Bruce IN; Thomson W
Rheumatology (Oxford); 2007 Oct; 46(10):1520-4. PubMed ID: 17586865
[TBL] [Abstract][Full Text] [Related]
9. Management of established rheumatoid arthritis with an emphasis on pharmacotherapy.
Blom M; van Riel PL
Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):43-57. PubMed ID: 17350543
[TBL] [Abstract][Full Text] [Related]
10. Patient-reported outcomes in a randomized trial comparing four different treatment strategies in recent-onset rheumatoid arthritis.
van der Kooij SM; de Vries-Bouwstra JK; Goekoop-Ruiterman YP; Ewals JA; Han KH; Hazes JM; Kerstens PJ; Peeters AJ; van Zeben D; Breedveld FC; Huizinga TW; Dijkmans BA; Allaart CF
Arthritis Rheum; 2009 Jan; 61(1):4-12. PubMed ID: 19116965
[TBL] [Abstract][Full Text] [Related]
11. Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?
Bansard C; Lequerré T; Daveau M; Boyer O; Tron F; Salier JP; Vittecoq O; Le-Loët X
Rheumatology (Oxford); 2009 Sep; 48(9):1021-8. PubMed ID: 19483089
[TBL] [Abstract][Full Text] [Related]
12. Patients with moderate rheumatoid arthritis (RA) achieve better disease activity states with etanercept treatment than patients with severe RA.
Keystone E; Freundlich B; Schiff M; Li J; Hooper M
J Rheumatol; 2009 Mar; 36(3):522-31. PubMed ID: 19228659
[TBL] [Abstract][Full Text] [Related]
13. Aggressive treatment of early rheumatoid arthritis to prevent joint damage.
Pincus T
Bull Rheum Dis; 1998 Dec; 47(8):2-7. PubMed ID: 9926484
[No Abstract] [Full Text] [Related]
14. An update on methotrexate.
Braun J; Rau R
Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
[TBL] [Abstract][Full Text] [Related]
15. Challenges of predicting treatment response in patients with rheumatoid arthritis.
Smolen JS; Aletaha D
Nat Clin Pract Rheumatol; 2005 Dec; 1(2):62-3. PubMed ID: 16932630
[No Abstract] [Full Text] [Related]
16. Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression.
van Roon JA; Jacobs K; Verstappen S; Bijlsma J; Lafeber F
Ann Rheum Dis; 2008 Jul; 67(7):1054-5. PubMed ID: 18556451
[No Abstract] [Full Text] [Related]
17. The BeSt story: on strategy trials in rheumatoid arthritis.
Klarenbeek NB; Allaart CF; Kerstens PJ; Huizinga TW; Dijkmans BA
Curr Opin Rheumatol; 2009 May; 21(3):291-8. PubMed ID: 19318946
[TBL] [Abstract][Full Text] [Related]
18. Unmet needs in rheumatoid arthritis.
Bykerk V
J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
[TBL] [Abstract][Full Text] [Related]
19. [Rheumatoid arthritis - target-oriented treatment focussing remission].
Fiehn C
Dtsch Med Wochenschr; 2012 Feb; 137(5):206-9. PubMed ID: 22278692
[No Abstract] [Full Text] [Related]
20. Use of parenteral methotrexate significantly reduces the need for biological therapy.
Bharadwaj A; Agrawal S; Batley M; Hammond A
Rheumatology (Oxford); 2008 Feb; 47(2):222. PubMed ID: 18056146
[No Abstract] [Full Text] [Related]
[Next] [New Search]
